Titania nanoparticles damage enveloped viruses by directly binding with membrane phospholipids – a previously unknown mode of antiviral action ...
Scientists have developed a simulation method incorporating quantum mechanics to model the electronic structure of nearly ...
The antiviral combination of nirmatrelvir and ritonavir (brand name Paxlovid) is an effective treatment for people with COVID ...
Researchers developed a model that detects SARS-CoV-2 mutations linked to increased transmission, identifying high-risk ...
Researchers have developed a powerful tool that can detect variants of SARS-CoV-2 with high transmission potential before ...
IFLScience on MSN8d
Nanoparticle Vaccine Could Protect Against Future COVID-19 Variants – Plus Other CoronavirusesA newly developed vaccine against a group of viruses including SARS-CoV-2 is producing promising results in mice, part of the ...
A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth ...
News Medical on MSN7d
In silico docking of clinically approved drugs against the SARS-CoV-2 receptor-binding domainAnnouncing a new article publication for BIO Integration journal. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in China in December 2019, rapidly spread worldwide, ...
“Although individual vaccines have been developed and approved for use in humans against SARS-CoV-2 and influenza viruses, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback